Contact
searchSearch
HMP Global

August 2015 - FRMC

Improving Remission Rates in Patients With Major Depressive Disorder
09/24/2015
Jill Sederstorm
Certain factors have been shown to lead to better outcomes 
Certain factors have been shown to lead to better outcomes 
Certain factors have been...
09/24/2015
First Report Managed Care
Why It Takes a Village to Help Diabetes Patients Achieve Multiple Treatment Goals
09/24/2015
Jill Sederstorm
Fewer complications occur when patients with diabetes have simultaneous control of A1c values, blood pressure (BP), and low-density lipoprotein (LDL). According to a session at CRS, it is possible to achieve all 3 aims in a primary care...
Fewer complications occur when patients with diabetes have simultaneous control of A1c values, blood pressure (BP), and low-density lipoprotein (LDL). According to a session at CRS, it is possible to achieve all 3 aims in a primary care...
Fewer complications occur when...
09/24/2015
First Report Managed Care
Adopting Biosimilars in the US: Overcoming the Obstacles
09/24/2015
Mary Beth Nierengarten
Europe and other countries lead the US in bringing biosimilars to market, according to Steven Miller, MD, vice president, chief medical officer, Express Scripts.
Europe and other countries lead the US in bringing biosimilars to market, according to Steven Miller, MD, vice president, chief medical officer, Express Scripts.
Europe and other countries lead...
09/24/2015
First Report Managed Care
Trials of Incretin Drugs Examine Cardiovascular Risk
09/24/2015
Eileen Koutnik-Fotopoulos
Outcomes from 2 major cardiovascular (CV) trials of the DPP-4 inhibitor sitagliptin and the glucagon- GLP-1 receptor agonist lixisenatide were presented at the ADA meeting.
Outcomes from 2 major cardiovascular (CV) trials of the DPP-4 inhibitor sitagliptin and the glucagon- GLP-1 receptor agonist lixisenatide were presented at the ADA meeting.
Outcomes from 2 major...
09/24/2015
First Report Managed Care
Emerging Trends in Insulin Therapy
09/24/2015
Eileen Koutnik-Fotopoulos
Many individuals with diabetes have suboptimal HbA1c control. Adding more than 2 to 3 oral medications may not achieve glycemic targets, and adherence is not always optimal.
Many individuals with diabetes have suboptimal HbA1c control. Adding more than 2 to 3 oral medications may not achieve glycemic targets, and adherence is not always optimal.
Many individuals with diabetes...
09/24/2015
First Report Managed Care
More Guidance Needed on Mental Health Aspects of Diabetes
09/08/2015
NULL
NULL
Boston, MA—Individuals with diabetes are more than twice as likely to face depression or varying degrees of mental health issues as individuals without the disease. Data from the World Health Organization (WHO) shows that mental health...
Boston, MA—Individuals with diabetes are more than twice as likely to face depression or varying degrees of mental health issues as individuals without the disease. Data from the World Health Organization (WHO) shows that mental health...
Boston, MA—Individuals with...
09/08/2015
First Report Managed Care

Department

Conference Insider
Strategies to Reduce Avoidable Hospitalization Among the Elderly
09/24/2015
Eileen Koutnik-Fotopoulos
Nursing home residents often experience avoidable inpatient hospitalizations.
Nursing home residents often experience avoidable inpatient hospitalizations.
Nursing home residents often...
09/24/2015
First Report Managed Care
Conference Insider
Comorbidities of Psoriatic Disease
09/24/2015
Mary Mihalovic
Psoriatic disease is now understood to be a systemic condition with a link to cardiometabolic risk as well as other comorbidities, including some types of cancers.
Psoriatic disease is now understood to be a systemic condition with a link to cardiometabolic risk as well as other comorbidities, including some types of cancers.
Psoriatic disease is now...
09/24/2015
First Report Managed Care
Conference Insider
Translating Trial Results Into Real-World Practice in IMIDs
09/24/2015
Mary Mihalovic
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical...
09/24/2015
First Report Managed Care

Column

Viewpoint
Tips for Alleviating the Psychosocial Issues of Psoriasis
09/24/2015
Richard G. Fried, MD, PhD
Both clinicians and patients living with psoriasis know that this chronic and capricious disease can have deleterious effects on the psyche.
Both clinicians and patients living with psoriasis know that this chronic and capricious disease can have deleterious effects on the psyche.
Both clinicians and patients...
09/24/2015
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

Elizabeth Brem University of California Irvine
Videos
Analyzing Patient Selection and the Utility of CNS Prophylaxis for Patients With DLBCL
04/20/2023
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great Debates & Updates in Hematologic Malignancies conference in New York, New York, Elizabeth A. Brem, MD, analyzed the role of central nervous system prophylaxis for patients with DLBCL.
In a debate at the 2023 Great...
04/20/2023
Oncology
News
Thousands Face Medicaid Coverage Disruptions in South Dakota and North Carolina
05/18/2023
Arielle Zionts
Now that the public health emergency has expired, individuals may lose coverage but then requalify several months later in states which have recently approved Medicaid expansion.
Now that the public health emergency has expired, individuals may lose coverage but then requalify several months later in states which have recently approved Medicaid expansion.
Now that the public health...
05/18/2023
First Report Managed Care
News
Digital Therapeutics "Viable Solution" for Mental Health Needs
06/07/2023
Jolynn Tumolo
“The participants were willing to utilize digital therapeutics if available, and even preferred this type of support compared to actually visiting a clinic,” researchers wrote.
“The participants were willing to utilize digital therapeutics if available, and even preferred this type of support compared to actually visiting a clinic,” researchers wrote.
“The participants were willing...
06/07/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
Amanda Balbi
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
First Report Managed Care
Stock image of a doctor holding a phone
Commentary
Prescription Digital Therapeutics: Ongoing Efforts to Expand Awareness, Integrate Into Clinical Practice
07/28/2023
Yvette C. Terrie, BS Pharm, RPh
Yvette Terrie shares digital therapeutic updates regarding FDA approvals, recent and upcoming clinical trials, and current industry regulations.
Yvette Terrie shares digital therapeutic updates regarding FDA approvals, recent and upcoming clinical trials, and current industry regulations.
Yvette Terrie shares digital...
07/28/2023
First Report Managed Care

August 2015 Volume 12 Issue 8

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use